CEO OF PIRAMAL
-
Piramal Pharma Solutions invests USD 10 mn to expand its API capability in US
The new wing at the Riverview site is dedicated to the production of HPAPIs with low occupational exposure levels (OELs), Piramal Pharma Solutions said in a statement.
Advertisement
Advertisement